Filing Details

Accession Number:
0001140361-15-012316
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-17 18:03:33
Reporting Period:
2015-03-13
Filing Date:
2015-03-17
Accepted Time:
2015-03-17 18:03:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380710 Eric George Davis C/O Biomarin Pharmaceutical Inc.
770 Lindaro St.
San Rafael CA 94901
Svp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-13 516 $26.49 74,362 No 4 M Direct
Common Stock Acquisiton 2015-03-13 14,484 $37.46 88,846 No 4 M Direct
Common Stock Disposition 2015-03-13 15,000 $120.87 73,846 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Common Stock Disposition 2015-03-13 516 $0.00 516 $26.49
Common Stock Stock Option (right to buy) Common Stock Disposition 2015-03-13 14,484 $0.00 14,484 $37.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,709 2011-11-12 2021-05-11 No 4 M Direct
15,347 2012-11-08 2022-05-07 No 4 M Direct
Footnotes
  1. The price in column is a weighted average price. The price actually received ranged from $120.79 to $121.055. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
  2. Original option grant vests 6/48ths on November 12, 2011, and 1/48th on the 12th day of every month thereafter.
  3. Reflects the number of stocks options that remain outstanding from this specific stock option grant following the reported transaction.
  4. Original option grant vests 6/48ths on November 8, 2012, and 1/48th on the 8th day of every month thereafter.